Seeking Alpha

The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally...

The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally disintegrating tablets to treat schizophrenia and bipolar disorder. The drugs will be jointly manufactured and distributed by Dr. Reddy's Labs (RDY +1%), Teva Pharmaceuticals (TEVA +0.9%) and Par Pharmaceuticals (PRX +1.9%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|